BridgeBio Pharma (BBIO) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free BBIO Stock Alerts $24.88 +0.55 (+2.26%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineabrdn plc Invests $11.51 Million in BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - April 26 at 6:13 AMDuality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - April 22 at 11:53 AMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Holdings Lowered by Vontobel Holding Ltd.marketbeat.com - April 21 at 5:24 AMBridgeBio Pharma Inc (BBIO)uk.investing.com - April 20 at 9:50 AMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Short Interest Updateamericanbankingnews.com - April 17 at 5:12 AMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Short Interest Up 6.5% in Marchmarketbeat.com - April 16 at 12:23 PMBridgeBio Pharma (NASDAQ:BBIO) Trading Down 5.7%marketbeat.com - April 12 at 3:17 PMBridgeBio Pharma, Inc. (BBIO)finance.yahoo.com - April 11 at 7:35 AMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 10 at 7:30 AMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 10 at 7:30 AMBuy Rating Affirmed for BridgeBio Pharma on Acoramidis’ Positive ATTR-CM Trial Outcomesmarkets.businessinsider.com - April 8 at 9:40 AMBridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)globenewswire.com - April 7 at 1:15 PMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Analystsmarketbeat.com - April 6 at 2:58 AMVanguard Group Inc. Trims Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - March 28 at 4:23 AMBridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $29.76marketbeat.com - March 27 at 12:23 PMAmerican Century Companies Inc. Boosts Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - March 25 at 4:08 AMBuy Rating Justified for BridgeBio Pharma Amidst Promising Long-Term Market Prospects for ATTR-CM Treatmentsmarkets.businessinsider.com - March 25 at 3:01 AMBridgeBio Pharma: Assessing Acoramidis' Market Opportunity, Further Upside Potential Evidentseekingalpha.com - March 22 at 6:49 AMRaymond James Begins Coverage on BridgeBio Pharma (NASDAQ:BBIO)marketbeat.com - March 21 at 8:20 AMWellington Management Group LLP Acquires New Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - March 21 at 4:26 AMAnalysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Jazz Pharmaceuticals (JAZZ)markets.businessinsider.com - March 20 at 5:39 PMBridgeBio Pharma (NASDAQ:BBIO) Given New $45.00 Price Target at JPMorgan Chase & Co.marketbeat.com - March 20 at 8:11 AMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 20 at 7:30 AMBBIO Mar 2024 32.000 callfinance.yahoo.com - March 19 at 10:37 PMBridgeBio Pharma (NASDAQ:BBIO) Price Target Increased to $70.00 by Analysts at Cantor Fitzgeraldmarketbeat.com - March 19 at 8:47 AMValidea Detailed Fundamental Analysis - BBIOnasdaq.com - March 17 at 11:46 PMBBIO Mar 2024 30.000 callfinance.yahoo.com - March 16 at 10:21 AMBBIO Mar 2024 30.000 putca.finance.yahoo.com - March 16 at 12:03 AMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Stock Position Increased by The Manufacturers Life Insurance Companymarketbeat.com - March 13 at 5:41 AMBBIO Mar 2024 25.000 putfinance.yahoo.com - March 9 at 12:44 PMBBIO Mar 2024 31.000 callca.finance.yahoo.com - March 9 at 7:44 AMBridgeBio Pharma, Inc. (NASDAQ:BBIO) Expected to Earn FY2026 Earnings of ($1.06) Per Sharemarketbeat.com - March 8 at 7:22 AMBBIO Mar 2024 25.000 callca.finance.yahoo.com - March 7 at 8:12 AMBridgeBio Pharma launches $250 million stock offeringuk.investing.com - March 6 at 4:54 PMBridgeBio prices $250M stock offeringmsn.com - March 6 at 4:54 PMBridgeBio Pharma Prices Offering Of $250 Mln Of Sharesmarkets.businessinsider.com - March 6 at 4:54 PMGSA Capital Partners LLP Makes New $2.27 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)marketbeat.com - March 6 at 2:34 PMBridgeBio Pharma (NASDAQ:BBIO) Sees Unusually-High Trading Volumemarketbeat.com - March 6 at 1:55 PMLeerink Partnrs Weighs in on BridgeBio Pharma, Inc.'s Q1 2024 Earnings (NASDAQ:BBIO)marketbeat.com - March 6 at 7:47 AMBridgeBio Pharma Announces Pricing of Public Offering of Common Stockglobenewswire.com - March 5 at 11:53 PMMizuho Lowers BridgeBio Pharma (NASDAQ:BBIO) Price Target to $53.00marketbeat.com - March 5 at 8:19 AMBBIO Mar 2024 31.000 putfinance.yahoo.com - March 5 at 1:24 AMBridgeBio Pharma Commences Public Offering Of $250 Mln Of Shares; Stock Downnasdaq.com - March 5 at 1:24 AMMaintained Buy Rating for BridgeBio Pharma Amidst Strategic Partnerships and Market Growth Potentialmarkets.businessinsider.com - March 4 at 8:23 PM2 Bay Area biotechs look to raise collective $550 million following deal, trial newsbizjournals.com - March 4 at 8:23 PMBridgeBio Pharma Announces Proposed Public Offering of Common Stockglobenewswire.com - March 4 at 4:17 PMTD Cowen Keeps Their Buy Rating on BridgeBio Pharma (BBIO)markets.businessinsider.com - March 4 at 3:22 PMWhat's Going On With BridgeBio Pharma Stock On Monday?msn.com - March 4 at 3:22 PMBridgeBio Dives After Inking A $310 Million Deal With Bayer For Its Lead Drugfinance.yahoo.com - March 4 at 10:22 AMBridgeBio Pharma (NASDAQ:BBIO) Earns Buy Rating from HC Wainwrightmarketbeat.com - March 4 at 8:24 AM Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. BBIO Media Mentions By Week BBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.260.32▲Average Medical News Sentiment BBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼55▲BBIO Articles Average Week Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Organon & Co. News Madrigal Pharmaceuticals News Alpine Immune Sciences News Nuvalent News Perrigo News Alkermes News Insmed News CymaBay Therapeutics News Blueprint Medicines News Biohaven News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
